nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—Osteopontin Signaling—PLAU—meningioma	0.0417	0.0417	CbGpPWpGaD
Glucosamine—MMP9—Collagen degradation—CTSL—meningioma	0.0393	0.0393	CbGpPWpGaD
Glucosamine—MMP9—Assembly of collagen fibrils and other multimeric structures—CTSL—meningioma	0.0305	0.0305	CbGpPWpGaD
Glucosamine—TNF—Cellular roles of Anthrax toxin—PGR—meningioma	0.0296	0.0296	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—PLAUR—meningioma	0.0289	0.0289	CbGpPWpGaD
Glucosamine—MMP9—Angiogenesis—PDGFB—meningioma	0.0263	0.0263	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—meningioma	0.0258	0.0258	CbGpPWpGaD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.0241	0.0241	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—meningioma	0.0233	0.0233	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—CTSL—meningioma	0.0224	0.0224	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—CST3—meningioma	0.0222	0.0222	CbGpPWpGaD
Glucosamine—MMP9—Osteopontin-mediated events—PLAU—meningioma	0.0208	0.0208	CbGpPWpGaD
Glucosamine—MMP9—Collagen formation—CTSL—meningioma	0.0208	0.0208	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—PLAU—meningioma	0.0203	0.0203	CbGpPWpGaD
Glucosamine—MMP9—Degradation of the extracellular matrix—CTSL—meningioma	0.0199	0.0199	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—HES1—meningioma	0.0198	0.0198	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—PLAUR—meningioma	0.019	0.019	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—meningioma	0.0181	0.0181	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—PLAUR—meningioma	0.0177	0.0177	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—PDGFB—meningioma	0.0172	0.0172	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—PLAU—meningioma	0.0164	0.0164	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—meningioma	0.0163	0.0163	CbGpPWpGaD
Glucosamine—NFKB2—Neural Crest Differentiation—HES1—meningioma	0.0159	0.0159	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—PLAU—meningioma	0.0143	0.0143	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—PLAU—meningioma	0.0134	0.0134	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—PLAU—meningioma	0.0124	0.0124	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—PLAU—meningioma	0.0124	0.0124	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—PLAU—meningioma	0.0117	0.0117	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—HES1—meningioma	0.0112	0.0112	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.0112	0.0112	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—PLAU—meningioma	0.0109	0.0109	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—PLAU—meningioma	0.0104	0.0104	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—AKT1—meningioma	0.00903	0.00903	CbGpPWpGaD
Glucosamine—MMP9—Angiogenesis—AKT1—meningioma	0.00867	0.00867	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—ERBB2—meningioma	0.00857	0.00857	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—PTEN—meningioma	0.00844	0.00844	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—CTSL—meningioma	0.00833	0.00833	CbGpPWpGaD
Glucosamine—NFKB2—TSLP Signaling Pathway—AKT1—meningioma	0.00825	0.00825	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—meningioma	0.00745	0.00745	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—PTEN—meningioma	0.00731	0.00731	CbGpPWpGaD
Glucosamine—NFKB2—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00728	0.00728	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CTSL—meningioma	0.00725	0.00725	CbGpPWpGaD
Glucosamine—IFNG—IFN-gamma pathway—AKT1—meningioma	0.00718	0.00718	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AP1B1—meningioma	0.00656	0.00656	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—PTEN—meningioma	0.00639	0.00639	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PDGFB—meningioma	0.00639	0.00639	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—PTEN—meningioma	0.0061	0.0061	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00609	0.00609	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—meningioma	0.00603	0.00603	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—meningioma	0.00576	0.00576	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.00565	0.00565	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—AKT1—meningioma	0.00554	0.00554	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00547	0.00547	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AP1B1—meningioma	0.00531	0.00531	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—meningioma	0.00507	0.00507	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—meningioma	0.00499	0.00499	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—AKT1—meningioma	0.00498	0.00498	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—AKT1—meningioma	0.00482	0.00482	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—AKT1—meningioma	0.00453	0.00453	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00444	0.00444	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD34—meningioma	0.00443	0.00443	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—meningioma	0.00436	0.00436	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—meningioma	0.00435	0.00435	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—AKT1—meningioma	0.00428	0.00428	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB2—meningioma	0.00428	0.00428	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CTSL—meningioma	0.00423	0.00423	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—HES1—meningioma	0.00422	0.00422	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—AKT1—meningioma	0.00421	0.00421	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—meningioma	0.00416	0.00416	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—meningioma	0.00396	0.00396	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—AKT1—meningioma	0.00396	0.00396	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—AKT1—meningioma	0.00396	0.00396	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—PDGFB—meningioma	0.00387	0.00387	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—AKT1—meningioma	0.00386	0.00386	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—meningioma	0.00379	0.00379	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PTEN—meningioma	0.00365	0.00365	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD34—meningioma	0.00359	0.00359	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00347	0.00347	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTSL—meningioma	0.00342	0.00342	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—PDGFB—meningioma	0.0034	0.0034	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—AKT1—meningioma	0.00339	0.00339	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PDGFB—meningioma	0.00337	0.00337	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—AKT1—meningioma	0.00318	0.00318	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—AKT1—meningioma	0.00305	0.00305	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	0.00295	0.00295	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—meningioma	0.00287	0.00287	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—meningioma	0.00282	0.00282	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—meningioma	0.0028	0.0028	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HES1—meningioma	0.00274	0.00274	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—AKT1—meningioma	0.00274	0.00274	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—AKT1—meningioma	0.00266	0.00266	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—meningioma	0.00242	0.00242	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—meningioma	0.00231	0.00231	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—meningioma	0.00226	0.00226	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—meningioma	0.0022	0.0022	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—AKT1—meningioma	0.0021	0.0021	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00206	0.00206	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PDGFB—meningioma	0.00196	0.00196	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—meningioma	0.00195	0.00195	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00195	0.00195	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PTEN—meningioma	0.00193	0.00193	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—AKT1—meningioma	0.00181	0.00181	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—meningioma	0.00176	0.00176	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00175	0.00175	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HES1—meningioma	0.00168	0.00168	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00167	0.00167	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TSHB—meningioma	0.00163	0.00163	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PDGFB—meningioma	0.00159	0.00159	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—meningioma	0.00157	0.00157	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—meningioma	0.00141	0.00141	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMO—meningioma	0.00139	0.00139	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PGR—meningioma	0.00133	0.00133	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—meningioma	0.00133	0.00133	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—meningioma	0.00132	0.00132	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.0013	0.0013	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.0012	0.0012	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—meningioma	0.00119	0.00119	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTEN—meningioma	0.00112	0.00112	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—meningioma	0.00112	0.00112	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—meningioma	0.00111	0.00111	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALAD—meningioma	0.00108	0.00108	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—meningioma	0.00107	0.00107	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00101	0.00101	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—meningioma	0.000961	0.000961	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HES1—meningioma	0.000911	0.000911	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTEN—meningioma	0.000909	0.000909	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALAD—meningioma	0.000834	0.000834	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PDGFB—meningioma	0.000779	0.000779	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—meningioma	0.000772	0.000772	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TSHB—meningioma	0.000697	0.000697	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—meningioma	0.000646	0.000646	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TSHB—meningioma	0.000538	0.000538	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—meningioma	0.000524	0.000524	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—meningioma	0.000522	0.000522	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—meningioma	0.000472	0.000472	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTEN—meningioma	0.000445	0.000445	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000329	0.000329	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—meningioma	0.000304	0.000304	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—meningioma	0.000257	0.000257	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTEN—meningioma	0.00019	0.00019	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTEN—meningioma	0.000146	0.000146	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—meningioma	0.000109	0.000109	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—meningioma	8.44e-05	8.44e-05	CbGpPWpGaD
